(Q44210953)

30 November 2017

title

Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial (English)

1 reference

30 November 2017

0 references

1 reference

1

Beatrice Amadi

1 reference

30 November 2017

Mwiya Mwiya

2

1 reference

30 November 2017

John Musuku

3

1 reference

30 November 2017

Angela Watuka

4

1 reference

30 November 2017

Sandie Sianongo

5

1 reference

30 November 2017

Ayman Ayoub

6

1 reference

30 November 2017

Paul Kelly

7

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

360

1 reference

30 November 2017

issue

9343

1 reference

30 November 2017

page(s)

1375-1380

1 reference

Cryptosporidiosis: an emerging, highly infectious threat

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Human cryptosporidiosis: epidemiology, transmission, clinical disease, treatment, and diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Practice guidelines for the management of infectious diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Cryptosporidium infection in infancy as a cause of malnutrition: a community study from Guinea-Bissau, west Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Persistent Diarrhea Signals a Critical Period of Increased Diarrhea Burdens and Nutritional Shortfalls: A Prospective Cohort Study among Children in Northeastern Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Cryptosporidiosis in infancy and childhood mortality in Guinea Bissau, west Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Intestinal and systemic infection, HIV, and mortality in Zambian children with persistent diarrhea and malnutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Treatment of intestinal parasitic infections: a review of nitazoxanide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Evaluation of new anti-infective drugs for the treatment of diarrhea caused by Giardia lamblia. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Case management of kwashiorkor: an intervention project at seven nutrition rehabilitation centres in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

Cryptosporidium, chronic diarrhoea and the proximal small intestinal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

The refeeding syndrome: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911401-2

7 January 2021

10.1016/S0140-6736(02)11401-2

Identifiers

DOI

1 reference

30 November 2017

1 reference